PD

Philippe Duchateau

CE Cellectis: 43 patents #1 of 71Top 2%
CS Cellectis Sa: 6 patents #1 of 37Top 3%
Pfizer: 3 patents #1,612 of 5,153Top 35%
AF Albert-Ludwigs-Universitaet Freiburg: 1 patents #93 of 368Top 30%
📍 Draveil, FR: #2 of 82 inventorsTop 3%
Overall (All Time): #49,842 of 4,157,543Top 2%
52
Patents All Time

Issued Patents All Time

Showing 26–50 of 52 patents

Patent #TitleCo-InventorsDate
11014989 Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy Julianne Smith, Julien Valton, Alexandre Juillerat, Barbra Johnson SASU, Arvind Rajpal 2021-05-25
10988542 Chimeric antigen receptors with integrated controllable functions Alexandre Juillerat, Laurent POIROT 2021-04-27
10894093 Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation Julien Valton, Veronique Zennou, Laurent POIROT 2021-01-19
10870864 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system Andre Choulika, Laurent POIROT 2020-12-22
10836998 Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells Laurent POIROT 2020-11-17
10813951 Method of engineering chemotherapy drug resistant T-cells for immunotherapy Julien Valton, David Sourdive 2020-10-27
10815500 Transcription activator-like effector (TALE) fusion protein Alexandre Juillerat 2020-10-27
10584352 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system Andre Choulika, Laurent POIROT 2020-03-10
10526406 Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish Julien Valton 2020-01-07
10508289 Rare-cutting endonucleases for efficient and specific targeting DNA sequences comprising highly repetitive motives Alexandre Juillerat 2019-12-17
10472613 Method for modulating car-induced immune cells activity Alexandre Juillerat, Laurent POIROT 2019-11-12
10472396 Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins Claudia Bertonati, Alexandre Juillerat, George H. Silva, Julien Valton 2019-11-12
10378007 Methods for modulating TAL specificity Alexandre Juillerat 2019-08-13
10301614 Method to overcome DNA chemical modifications sensitivity of engineered tale DNA binding domains Julien Valton 2019-05-28
10294304 Chimeric antigen receptors targeting B-cell maturation antigen Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Roman Galetto, Alexandre Juillerat +6 more 2019-05-21
10239948 Method of engineering multi-input signal sensitive T cell for immunotherapy Alexandre Juillerat, Claudia Bertonati, Julien Valton, Laurent POIROT 2019-03-26
10196608 Method for in situ inhibition of regulatory T cells Laurent POIROT 2019-02-05
10087453 Modified diatoms for biofuel production Fayza DABOUSSI, David Sourdive, Jean-Charles Epinat 2018-10-02
9890393 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system Andre Choulika, Laurent POIROT 2018-02-13
9855297 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system Andre Choulika, Laurent POIROT 2018-01-02
9315788 Method for the generation of compact TALE-nucleases and uses thereof Julien Valton, Claudia Bertonati, Jean-Charles Epinat, George H. Silva, Alexandre Juillerat +1 more 2016-04-19
9044492 Method for modulating the efficiency of double-strand break-induced mutagenesis Fabien Delacote, Christophe Perez-Michaut 2015-06-02
8906607 Method for modulating double-strand break-induced homologous recombination Frederic Paques, Christophe Perez-Michaut, Fabien Delacote 2014-12-09
8715992 I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof Frederic Paques 2014-05-06
8530214 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof Sylvain Arnould, Patrick Chames, Jean-Charles Epinat, Emmanuel Lacroix, Frederic Paques 2013-09-10